Intellia Therapeutics
NTLA
NTLA
289 hedge funds and large institutions have $3.19B invested in Intellia Therapeutics in 2023 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 108 increasing their positions, 72 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.64% less ownership
Funds ownership: 89.44% → 88.8% (-0.64%)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
52% less call options, than puts
Call options by funds: $15.1M | Put options by funds: $31.5M
Holders
289
Holding in Top 10
6
Calls
$15.1M
Puts
$31.5M
Top Buyers
| 1 | +$28.8M | |
| 2 | +$17.8M | |
| 3 | +$12.4M | |
| 4 |
CIM
Contrarius Investment Management
St. Helier,
Jersey
|
+$12M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$11.5M |
Top Sellers
| 1 | -$58.5M | |
| 2 | -$37.9M | |
| 3 | -$22.7M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$14.3M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$12.7M |